Form 8-K - Current report:
SEC Accession No. 0001213900-17-008560
Filing Date
2017-08-14
Accepted
2017-08-14 09:58:00
Documents
2
Period of Report
2017-08-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k081017_immucellcorp.htm 8-K 20957
2 LETTER OF RESIGNATION FROM DR. RHODES TO THE COMPANY DATED AUGUST 10, 2017. f8k081017ex99i_immucellcorp.htm EX-99.1 3020
  Complete submission text file 0001213900-17-008560.txt   25167
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 171027842
SIC: 2835 In Vitro & In Vivo Diagnostic Substances